Anaplastic Astrocytoma

Showing 1 - 25 of 101

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

Recruiting
  • Glioblastoma
  • +3 more
  • Adaptive Radiotherapy
  • New York, New York
    Columbia University Irving Medical Center
Oct 27, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

Not yet recruiting
  • Glioblastoma Multiforme
  • +4 more
  • SIACI of cetuximab and bevacizumab
  • Miami, Florida
    Jackson Memorial Hospital
Jul 14, 2023

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Targeted Pediatric High-Grade Glioma Therapy

    Not yet recruiting
    • High Grade Glioma
    • +8 more
      • Aurora, Colorado
      • +17 more
      May 1, 2023

      Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States

      Recruiting
      • Anaplastic Astrocytoma
      • +6 more
      • Biopsy
      • +3 more
      • Birmingham, Alabama
      • +62 more
      Feb 2, 2023

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

      Recruiting
      • Glioblastoma Multiforme
      • +2 more
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jan 30, 2023

      Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

      Not yet recruiting
      • Recurrent High Grade Glioma
      • +4 more
      • (no location specified)
      Jan 24, 2023

      Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

      Completed
      • Glioma
      • +7 more
      • Neural stem cells loaded with an oncolytic adenovirus
      • Duarte, California
      • +1 more
      Dec 28, 2022

      Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

      Completed
      • Diffuse Intrinsic Pontine Glioma
      • +6 more
      • Washington, District of Columbia
      • +6 more
      Jan 12, 2023

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

      Recruiting
      • Glioblastoma Multiforme
      • +5 more
      • Los Angeles, California
      • +12 more
      Jan 9, 2023

      Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

      Active, not recruiting
      • Anaplastic Astrocytoma
      • +2 more
      • Radiation Therapy
      • +2 more
      • Birmingham, Alabama
      • +162 more
      Dec 30, 2022

      Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

      Active, not recruiting
      • Glioma, Malignant
      • +4 more
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 28, 2022

      Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

      Recruiting
      • Glioblastoma Multiforme
      • Anaplastic Astrocytoma
      • New York, New York
        Lenox Hill Brain Tumor Center
      Nov 10, 2022

      Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

      Recruiting
      • Glioblastoma
      • +8 more
      • Intra-arterial Cetuximab
      • +2 more
      • New York, New York
        Lenox Hill Brain Tumor Center
      Oct 17, 2022

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

      Terminated
      • Glioblastoma Multiforme
      • +3 more
      • Indianapolis, Indiana
        Riley Hospital for Children at IU Health
      Jul 21, 2022

      Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

      Completed
      • Malignant Glioma
      • +3 more
      • Dendritic Cell Vaccine
      • +3 more
      • Miami, Florida
        University of Miami
      Jul 19, 2022

      Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

      Recruiting
      • Medulloblastoma
      • +7 more
      • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
      • +2 more
      • Buffalo, New York
      • +2 more
      Jul 8, 2022

      Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

      Active, not recruiting
      • Anaplastic Astrocytoma
      • +6 more
      • Laboratory Biomarker Analysis
      • +4 more
      • Los Angeles, California
      • +11 more
      Jul 1, 2022

      Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)

      Recruiting
      • Glioma
      • +8 more
      • MRI-guided laser ablation
      • +4 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jun 22, 2022

      Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

      Active, not recruiting
      • Brain Tumor, Recurrent
      • +4 more
      • Cytoreductive surgery
      • +2 more
      • New York, New York
      • +1 more
      Jun 9, 2022

      Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)

      Active, not recruiting
      • Supratentorial Neoplasms, Malignant
      • +6 more
      • G207
      • Birmingham, Alabama
      • +1 more
      Jun 1, 2022

      Loupe-Based Intraoperative Fluorescence Imaging

      Recruiting
      • Glioblastoma Multiforme
      • Anaplastic Astrocytoma
        • Lexington, Kentucky
          University of Kentucky
        Mar 3, 2022

        CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

        Recruiting
        • Central Nervous System Neoplasms
        • +22 more
        • Bethesda, Maryland
          National Institutes of Health
        Mar 1, 2022